Robert C. Malenka, Director at MapLight Therapeutics, Inc. (MPLT), sold 14,195 shares at $18.39 ($260K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Open-market sale of $260k MPLT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.03 | 2,195 | $40K | 15.2% |
| 2 | $18.39 | 10,788 | $198K | 76.2% |
| 3 | $19.06 | 476 | $9K | 3.5% |
| 4 | $18.15 | 736 | $13K | 5.1% |
| Total | $18.34 avg | 14,195 | $260K | 100% |
| Filing → |
| MPLT | SELL | 2026-02-12 | $124K | — | Filing → |
| MPLT | SELL | 2026-02-04 | $127K | — | Filing → |
| MPLT | SELL | 2026-01-30 | $636K | — | Filing → |